This video was supplied by the International Society of Cardiovascular Pharmacotherapy (ISCP) and discuses Cardiovascular risk management of diabetes and SGLT2 inhibitors

Lecturer: Masayuki Yoshida, Professor of Medicine, Tokyo Medical and Dental University, Japan
Interviewer： Koji Hasegawa, Leader, Cardiovascular Clinical Research Network, National Hospital Organization, Shizuoka, Japan